Bioreactors addressing diabetes mellitus

Journal of Diabetes Science and Technology

Volumn 8, Issue 6, 2014, Pages 1227-1232

  Minteer, Danielle M ^a   Gerlach, Jorg C ^b,c,d   Marra, Kacey G ^a,b,d  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bioreactor; Cell culture; Diabetes mellitus; Diabetes treatments

Indexed keywords

BIOREACTOR; CELL CULTURE; CELL THERAPY; DIABETES MELLITUS; EXPLANT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROGRAVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; TISSUE ENGINEERING; ANIMAL; DEVICES; EQUIPMENT DESIGN; PROCEDURES;

ANIMALS; BIOREACTORS; DIABETES MELLITUS; EQUIPMENT DESIGN; HUMANS; TISSUE ENGINEERING;

EID: 84925846705     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814548215     Document Type: Review

References (54)

1. Bilodeau K, Mantovani D. Bioreactors for tissue engineering: focus on mechanical constraints. A comparative review. Tissue Eng. 2006;12(8):2367-2383.
2. Gerlach JC, Lin YC, Minteer DM, Li H, Rubin JP, Marra KG. Adipogenesis of human adipose-derived stem cells within three-dimensional hollow fiber-based bioreactors. Tissue Eng C Methods. 2012;18(1):54-61.
3. Brayfield CA, Marra KG, Leonard JP, Cui XT, Gerlach JC. Excimer laser channel creation in polyethersulfone hollow fibers for compartmentalized in vitro neuronal cell culture scaffolds. Acta Biomat. 2008;4(2):244-255.
4. Miki T, Ring A, Gerlach JC. Three-dimensional dynamic perfusion culture conditions promote hepatic differentiation of human embryonic stem cells. Tissue Eng C Methods. 2011;17(5):557-568.
5. Gerlach JC, Hout M, Edsbagge J, et al. Dynamic 3D culture promotes spontaneous embryonic stem cell differentiation in vitro. Tissue Eng C Methods. 2010;16(1):115-121.
6. Gerlach JC, Lubberstedt M, Edsbagge J, et al. Interwoven fourcompartment capillary membrane technology for 3D perfusion with decentral mass exchange to scale-up embryonic stem cell culture. Cells Tissue Organs. 2010;192(1):39-49.
7. Ring A, Gerlach JC, Peters G, et al. Hepatic maturation of human fetal hepatocytes in four-compartment 3D perfusion culture. Tissue Eng C Methods. 2010;16(5):835-845.
8. Schmelzer E, Triolo F, Turner ME, et al. Three-dimensional perfusion bioreactor culture supports differentiation of human fetal liver cells. Tissue Eng A. 2010;16(6):2007-2016.
9. Stachelscheid H, Wulf-Goldenberg A, Eckert K, et al. Teratoma formation of human embryonic stem cells in threedimensional perfusion culture bioreactors. J Tissue Eng Regen Med. 2012;7(9):729-741.
10. Mauney JR, Nguyen T, Gillen K, et al. Engineering adiposelike tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds. Biomat. 2007;28:5280-5290.
11. Unsworth BR, Lelkes PI. Growing tissues in microgravity. Nature Med. 1998;4(8):901-907.
12. Hwang YS, Cho J, Tay F, et al. The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomat. 2009;30(4): 499-507.
13. Korossis SA, Bolland F, Kearney JN, Fisher J, Ingham E. Bioreactors in tissue engineering. Topics Tissue Eng. 2005;2(8):1-23.
14. Liao J, Guo X, Grande-Allen KJ, Kasper FK, Mikos AG. Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering. Biomat. 2010;31(34):8911-8920.
15. Bancroft GN, Sikavitsas VI, Mikos AG. Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng. 2003;9(3):549-554.
16. Irgang M, Sauer IM, Karlas A, et al. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol. 2004;28(2):141-154.
17. Miki T, Ring A, Gerlach JC. Hepatic differentiation of human embryonic stem cells is promoted by three-dimensional dynamic perfusion culture conditions. Tissue Eng C Methods. 2011;17(5):557-568.
18. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol. 2004;22(2):80-86.
19. Mol A, Driessen NJ, Rutten MC, Hoerstrup SP, Bouten CV, Baaijens FP. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng. 2005;33(12):1778-1788.
20. Moon DG, Christ G, Stitzel JD, Atala A, Yoo JJ. Cyclic mechanical preconditioning improves engineered muscle contraction. Tissue Eng A. 2008;14(4):473-482.
21. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005;54(2):S97-S107.
22. Montague CT, O'Rahilly S. The perils of portliness. Diabetes. 2000;49:883-888.
23. Pi-Sunyer FX. Health hazards of obesity. Ann Intern Med. 1993;119: 655-660.
24. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA. 2001;289:76-79.
25. Horowitz JF, Klein S. Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women Am J Physiol Endocrinol Metab. 2000;278:E1144-E1152.
26. Centers for Disease Control and Prevention. More than 29 million Americans have diabetes;1 in 4 doesn't know. Press release, June 10, 2014.
27. Minteer D, Marra KG, Rubin JP. Adipose-derived mesenchymal stem cells: biology and potential applications. In Mesenchymal Stem Cells-Basics and Clinical Application I. Berlin, Germany: Springer; 2013:59-71.
28. NASA Educational Brief. NASA's bioreactor: growing cells in a microgravity environment. EB-2002-12-187-MSFC.
29. Wong J. Cells in space. Nature Med. 1997;3(3):259-259.
30. Barzegari A, Saei AA. An update to space biomedical research: tissue engineering in microgravity bioreactors. BI. 2012;2(1):23.
31. Song C, Duan XQ, Li X, et al. Experimental study of rat beta islet cells cultured under simulated microgravity conditions. Acta biochimica et biophysica Sinica, 2004;36(1):47-50.
32. Song C, Duan XQ, Zhou Y, et al. Experimental study on islet cells in rats under condition of three-dimensional microgravity. Zhonghua Wai Ke Za Zhi. 2004;42(9):559-561.
33. Rutzky LP, Bilinski S, Kloc M, et al. Microgravity culture condition reduces immunogenicity and improves function of pancreatic islets1. Transplantation. 2002;74(1):13-21.
34. Murray HE, Paget MB, Downing R. Preservation of glucose responsiveness in human islets maintained in a rotational cell culture system. Mol Cell Endocrinol. 2005;238(1): 39-49.
35. Samuelson L, Gerber DA. Improved function and growth of pancreatic cells in a three-dimensional bioreactor environment. Tissue Eng C Methods. 2012;19(1):39-47.
36. Tanaka H, Tanaka S, Sekine K, et al. The generation of pancreatic β-cell spheroids in a simulated microgravity culture system. Biomat. 2013;34:5785-5791.
37. Stepkowski SM, Phan T, Zhang H, et al. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition. Transplantation. 2006;82:1756-1763.
38. Hoesli CA., Luu M, Piret JM. A novel alginate hollow fiber bioreactor process for cellular therapy applications. Biotechnol Prog. 2009;25(6):1740-1751.
39. Lu Y, Zhang G, Shen C, et al. A novel 3D organoid system for elucidation of hepatic glucose metabolism. Biotech Bioeng. 2012;109(2):595-604.
40. Chawla M, Bodnar CA, Sen A, Kallos MS, Behie LA. Production of islet-like structures from neonatal porcine pancreatic tissue in suspension bioreactors. Biotechnol Prog. 2006;22(2):561-567.
41. Dutt K, Sanford G, Harris-Hooker S, et al. Three-dimensional model of angiogenesis: coculture of human retinal cells with bovine aortic endothelial cells in the NASA bioreactor. Tissue Eng. 2003;9(5):893-908.
42. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs. 1997;21(11):1203-1210.
43. Kemmerrer SV, Bagley DK. DermagraftR scale-up case study. In Engineering in Medicine and Biology, 2002. 24th Annual Conference and the Annual Fall Meeting of the Biomedical Engineering Society EMBS/BMES Conference, 2002. Proceedings of the Second Joint. Vol. 1. New York, NY: IEEE; 2012:879-880.
44. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83:461S-4615S.
45. Summers SA, Garza LA, Zhou H. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and akt kinase activity by ceramide. Mol and Cell Biol. 1998;18(9):5457-5464.
46. Sivakumar G, Medina-Bolivar F, Lay J, et al. Bioprocess and bioreactor: next generation technology for production of potential plant-based antidiabetic and antioxidant molecules. Curr Med Chem. 2011;18(1):79-90.
47. Kanner J, Lapidot T. The stomach as a bioreactor: dietary lipid peroxidation in the gastric fluid and the effects of plant-derived antioxidants. Free Radical Biol Med. 2001;31(11):1388-1395.
48. Gorelik S, Ligumsky M, Kohen R, Kanner J. The stomach as a bioreactor: when red meat meets red wine. J Agricultural Food Chem. 2008;56(13):5002-5007.
49. Jung ES, Kim HJ, Oh DK. Tagatose production by immobilized recombinant escherichia coli cells containing geobacillus stearothermophilus L-arabinose isomerase mutant in a packedbed bioreactor. Biotecnol Prog. 2005;21:1335-1340.
50. Ho JAA, Wu LC, Fan NC, et al. Development of a long-life capillary enzyme bioreactor for the determination of blood glucose. Talanta. 2007;71(1):391-396.
51. Chick WL, et al. Cell culture device. US patent no. 4, 242, 459. December 30, 1980.
52. Reach G, Jaffrin MY. Kinetic modelling as a tool for the design of a vascular bioartificial pancreas: feedback between modelling and experimental validation. Comput Methods Programs Biomed. 1990;32(3):277-285.
53. Todisco S, Calabro V, Iorio G. A lumped parameter mathematical model of a hollow fiber membrane device for the controlled insulin release. J Membr Sci. 1995;106(3):221-232.
54. Papas KK, et al. A stirred microchamber for oxygen consumption rate measurements with pancreatic islets. Biotechnol Bioeng. 2007;98(5):1071-1082.